Email not displaying correctly? View it in your browser.
February 2018

Patient Care

CANARY noninvasively predicts histology and risk stratifies pulmonary nodules
Computer-Aided Nodule Assessment and Risk Yield (CANARY) image analysis software has shown promise in noninvasively predicting epithelial growth factor receptor (EGFR) status of adenocarcinoma of the lung, allowing for better selection of subjects for EGFR-targeted therapy without necessitating biopsy.

Center for Regenerative Medicine works to optimize brain performance after cancer treatment
Studies suggest that radiation used to treat brain tumors accelerates aging-like changes in the brain. Mayo researchers are working to minimize the amount of brain exposed to radiation and develop strategies to help rejuvenate the radiated brain.

Patients with lymphoma benefit from increased physical activity
Researchers found that patients with lymphoma who increased their level of physical activity after diagnosis had significantly better overall and lymphoma-specific survival than those who were less physically active.


Minorities with multiple myeloma less likely to receive stem cell therapy
Barriers to patients receiving stem cell therapy as part of their treatment for multiple myeloma include income, education, insurance status, and access to care at an academic center or facility that treats a high volume of patients.

Contrast-enhanced mammography shows promise as an alternative approach for evaluating residual cancer
Research indicates that contrast-enhanced digital mammography is comparable to breast MRI in evaluating residual breast cancer after neoadjuvant endocrine therapy or chemotherapy. Contrast-enhanced mammography is a potentially easier, faster, more accessible and more cost-effective option.

Zebrafish help researchers identify how neuroblastoma spreads
Genetic analyses using zebrafish demonstrate that LMO1 cooperates with the MYCN gene to accelerate tumor onset and increase tumor penetrance. Neuroblastoma spread is problematic for two-thirds of children who have high-risk disease at diagnosis.

See all Cancer Clinical Trials at Mayo Clinic

Back to Top


2nd Annual Therapeutic Advances for Advanced Practice Providers and Nurses: Hematology/Oncology Updates 2018
April 14, 2018, in Jacksonville, Fla.
This course provides treatment updates in hematology and oncology with a focus on the needs of physician assistants, advanced registered nurse practitioners, and hematology and oncology nurses. There will be a unique opportunity for discussion with world-renowned cancer specialists.

28th Annual Mayo Clinic Hematology/Oncology Reviews 2018
Aug. 1-4, 2018, in Fernandina Beach, Fla.
This comprehensive review focuses on the clinical application of new research developments and clinical management questions in highly interactive sessions. Participants receive up-to-date, practical information with immediate clinical application.

See all Hematology and Oncology Continuous Professional Development courses

In the Video Center

Unlocking the Power of Gene Expression: Molecular Classification of Brain Tumors
Researchers discuss how the molecular makeup of brain tumors can be used to identify categories of gliomas. That information can help predict both the prognosis and the kind of therapy that will be most effective for each patient.

Genes of Colon Cancer Recurrence Differ Among Blacks, Whites and Asians
Research indicates that the genetic makeup of colon cancer tumors and survival rates for patients with the disease differ by race — that cancer biology may contribute to race-based disparities. Future studies will examine potential biological drivers of the differences.

View videos by specialty and Grand Rounds presentations online

Back to Top

Consults & Referrals

Connect With Us

Facebook iconTwitter iconYoutube icon

Receive real-time news and thought-leading insight

Back to Top

Mayo Clinic
13400 E. Shea Blvd.
Scottsdale, AZ 85259

4500 San Pablo Road
Jacksonville, FL 32224

200 First St. SW
Rochester, MN 55905